Osaka University

View All

ATS 2023 Updates: AD109’s Potential as the First Oral Medication for Obstructive Sleep Apnea (OSA)

Apnimed’s AD109 has the potential to be the first oral pharmaceutical drug that remedies both, the primary cause of OSA, nocturnal airway obstruction, and the daytime symptoms of OSA, such as fatigue. The dual mode of action of AD109 leads to upper airway dilatation as well as enhanced breathing and oxygen...

Find More

Japan has got new ways to treat corneas

The Cornea- the outermost layer in the human eye, plays an important role in regulating the amount of light entering into the eye. It also protects the eye from germs, dust, and other harmful matter. Although this important part of the human body has a countless number of ways to get damaged. Corneal Abrasions, Dry...

Find More

artificial intelligence
Now, Artificial Intelligence to Accurately Identify Cancer Cells

In what could be regarded as a precursor to a new mode of cancer diagnosis, an artificial intelligence based tool, developed at the Osaka University in Japan, can precisely differentiate between different cancer cells, paving the way for automated determination of appropriate individualized cancer treatments. As a m...

Find More